Evidence map›Paper›PMID 37726371›Full record

ArticleScientific reports2023

Adverse event signal extraction from cancer patients' narratives focusing on impact on their daily-life activities.

Satoshi Nishioka, Masaki Asano, Shuntaro Yada, Eiji Aramaki, Hiroshi Yajima, Yuki Yanagisawa, Kyoko Sayama, Hayato Kizaki, Satoko Hori

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. CACER: Clinical concept Annotations for Cancer Events and Relations.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Satoshi NishiokaDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Masaki AsanoDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Shuntaro YadaNara Institute of Science and Technology, Nara, Japan.
Eiji AramakiNara Institute of Science and Technology, Nara, Japan.
Hiroshi YajimaMediaid Corporation, Tokyo, Japan.
Yuki YanagisawaDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Kyoko SayamaDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Hayato KizakiDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Satoko HoriDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan. satokoh@keio.jp.
Keio University · JPNara Institute of Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse event (AE) management is important to improve anti-cancer treatment outcomes, but it is known that some AE signals can be missed during clinical visits. In particular, AEs that affect patients' activities of daily living (ADL) need careful monitoring as they may require immediate medical intervention. This study aimed to build deep-learning (DL) models for extracting signals of AEs limiting ADL from patients' narratives. The data source was blog posts written in Japanese by breast cancer patients. After pre-processing and annotation for AE signals, three DL models (BERT, ELECTRA, and T5) were trained and tested in three different approaches for AE signal identification. The performances of the trained models were evaluated in terms of precision, recall, and F1 scores. From 2,272 blog posts, 191 and 702 articles were identified as describing AEs limiting ADL or not limiting ADL, respectively. Among tested DL modes and approaches, T5 showed the best F1 scores to identify articles with AE limiting ADL or all AE: 0.557 and 0.811, respectively. The most frequent AE signals were "pain or numbness", "fatigue" and "nausea". Our results suggest that this AE monitoring scheme focusing on patients' ADL has potential to reinforce current AE management provided by medical staff.

Indexed as

Breast NeoplasmsBryozoaActivities of Daily LivingAnimalsFemaleHumansHypesthesiaMedical Staff

Identifiers

PMID37726371
PMCPMC10509234
OpenAlexW4386844061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.